Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ESR1 | P03372 | 16/20 | 0.57 |
| ▸ | ESR2 | Q92731 | 16/20 | 0.57 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.57 |
| ▸ | SLC6A2 | P23975 | 2/20 | 0.57 |
| ▸ | AR | P10275 | 1/20 | 0.57 |
| ▸ | HPGD | P15428 | 1/20 | 0.57 |
| ▸ | TSHR | P16473 | 1/20 | 0.57 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.57 |
| ▸ | HTR6 | P50406 | 1/20 | 0.57 |
| ▸ | ESRRG | P62508 | 1/20 | 0.57 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.57 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.57 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.55 |
| ▸ | TAAR1 | Q96RJ0 | 2/20 | 0.44 |
| ▸ | MEN1 | O00255 | 1/20 | 0.43 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.43 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.43 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15475852 | 1.00 | ESR1 (0.57) | ESR1ESR2CYP3A4SLC6A2AR | |
| SCHEMBL28340138 | 0.92 | ESR1 (0.59) | ESR1ESR2CYP3A4SLC6A2AR | |
| Orthocresol SCHEMBL29223985 | 0.87 | ESR1 (0.50) | ESR1ESR2CYP3A4SLC6A2AR | |
| SCHEMBL30320268 | 0.86 | ESR1 (0.43) | ESR1ESR2CYP3A4SLC6A2AR | |
| SCHEMBL28680993 | 0.86 | ESR1 (0.43) | ESR1ESR2CYP3A4SLC6A2AR | |
| SCHEMBL231792 | 0.84 | ESR1 (0.61) | ESR1ESR2CYP3A4SLC6A2ALDH1A1 | |
| SCHEMBL10456186 | 0.84 | ESR1 (0.76) | ESR1ESR2CYP3A4SLC6A2AR | |
| SCHEMBL28684690 | 0.83 | ESR1 (0.53) | ESR1ESR2CYP3A4SLC6A2AR | |
| SCHEMBL5679013 | 0.82 | ESR1 (0.44) | ESR1ESR2CYP3A4SLC6A2AR | |
| Bisphenol A SCHEMBL268449 | 0.81 | ESR1 (0.61) | ESR1ESR2CYP3A4SLC6A2AR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0591984-B1 | Resin composition for aqueous paint | KANSAI PAINT CO LTD (JP) | 1997-07-09 | — | — | EP | claimed |
| US-9256126-B2 | Methanofullerenes | IRRESISTIBLE MATERIALS LTD (GB) | 2016-02-09 | — | — | US | disclosed |
| WO-2014137663-A1 | METHANOFULLERENES | ROBINSON ALEX PHILIP GRAHAM (GB) | 2014-09-12 | — | — | WO | disclosed |
| US-20140134843-A1 | Methanofullerenes | IRRESISTIBLE MATERIALS LTD (GB) | 2014-05-15 | — | — | US | disclosed |
| EP-2460856-A1 | POLYCARBONATE RESIN COMPOSITION | Idemitsu Kosan Co., Ltd. (JP) | 2012-06-06 | — | — | EP | disclosed |
| EP-1806618-B1 | POSITIVE PHOTOSENSITIVE INSULATING RESIN COMPOSITION AND CURED PRODUCT THEREOF | JSR CORP (JP) | 2010-06-09 | — | — | EP | disclosed |
| EP-1806618-A1 | POSITIVE PHOTOSENSITIVE INSULATING RESIN COMPOSITION AND CURED PRODUCT THEREOF | JSR Corporation (JP) | 2007-07-11 | — | — | EP | disclosed |
| EP-1469353-A1 | TWO-LAYER FILM AND METHOD OF FORMING PATTERN WITH THE SAME | JSR Corporation (JP) | 2004-10-20 | — | — | EP | disclosed |
| US-20020086934-A1 | Anti-reflection coating forming composition | JSR CORPORATION (JP) | 2002-07-04 | — | — | US | disclosed |
| EP-0695316-A1 | URETHANE MODIFIED EPOXY RESIN COMPOSITIONS | Ciba SC Holding AG (CH) | 1996-02-07 | — | — | EP | disclosed |
| WO-1995021879-A1 | URETHANE MODIFIED EPOXY RESIN COMPOSITIONS | CIBA-GEIGY AG (CH) | 1995-08-17 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140134843-A1 | Methanofullerenes | WASF2, ERCC4, TUFM | ESR1 1036/4885ESR2 1065/4885CYP3A4 1344/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.